v2.3.0.15
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (USD $)
Total
USD ($)
Series A Preferred Stock
USD ($)
Common Stock
USD ($)
Additional Paid-in Capital
USD ($)
Accumulated Deficit
USD ($)
Series B Preferred Stock
USD ($)
Director
USD ($)
Director
Series A Preferred Stock
USD ($)
Director
Common Stock
USD ($)
Director
Additional Paid-in Capital
USD ($)
cash, net of cash fees
USD ($)
cash, net of cash fees
Common Stock
USD ($)
cash, net of cash fees
Additional Paid-in Capital
USD ($)
Debt
USD ($)
Debt
Common Stock
USD ($)
Debt
Additional Paid-in Capital
USD ($)
Financing fees
USD ($)
Financing fees
Common Stock
USD ($)
Financing fees
Additional Paid-in Capital
USD ($)
Extensions of Debt
USD ($)
Extensions of Debt
Common Stock
USD ($)
Extensions of Debt
Additional Paid-in Capital
USD ($)
Accrued interest
USD ($)
Accrued interest
Common Stock
USD ($)
Accrued interest
Additional Paid-in Capital
USD ($)
Services
USD ($)
Services
Common Stock
USD ($)
Services
Additional Paid-in Capital
USD ($)
Trade payables
USD ($)
Trade payables
Common Stock
USD ($)
Trade payables
Additional Paid-in Capital
USD ($)
Patent
USD ($)
Patent
Common Stock
USD ($)
Patent
Additional Paid-in Capital
USD ($)
Conversion of Series B Preferred Stock
Common Stock
USD ($)
Conversion of Series B Preferred Stock
Additional Paid-in Capital
USD ($)
Conversion of Series B Preferred Stock
Series B Preferred Stock
USD ($)
Settlement of Debt obligation
USD ($)
Settlement of Debt obligation
Common Stock
USD ($)
Settlement of Debt obligation
Additional Paid-in Capital
USD ($)
litigation settlement
USD ($)
litigation settlement
Common Stock
USD ($)
litigation settlement
Additional Paid-in Capital
USD ($)
Employees as compensation and reimbursable expenses
USD ($)
Employees as compensation and reimbursable expenses
Common Stock
USD ($)
Employees as compensation and reimbursable expenses
Additional Paid-in Capital
USD ($)
pro forma
Common Stock
Beginning Balance at Dec. 31, 2008$ (2,752,263) $ 33,378$ 13,821,132$ (16,606,773)                                          
Beginning Balance (in shares) at Dec. 31, 2008  333,783,072                                            
Issuance of Series B Preferred Stock (in shares)     500,000                                         
Issuance of Series B Preferred Stock275,000  274,950 50                                         
Equity awarded for compensation and contingent compensation (in shares)  87,500,000                                            
Equity awarded for compensation and contingent compensation182,400 8,750173,650                                           
Deemed dividend on Series B Preferred Stock(985,000)  985,000(985,000)                                          
Common stock cancelled (In shares)  (250,000)                                            
Common stock cancelled  (25)25                                           
Net loss(2,439,851)   (2,439,851)                                          
After the March 21, 2011, 200-to-1 reverse stock split:                                               
Common stock and warrants issued (in shares)                          31,900,000                    
Common stock and warrants issued                         290,2003,190287,010                   
Common stock issued (in shares)           714,673,394  246,859,885        161,874,249  17,000,000     250,000,000 50,000,000 (500,000)          
Common stock issued          1,066,00071,467994,533157,75024,686133,064      286,44416,187270,257 1,700(1,700)   1,875,00025,0001,850,0005,000(4,950)(50)          
Ending Balance at Dec. 31, 2009(1,059,320) 189,33418,782,970(20,031,624)                                          
Ending Balance (in shares) at Dec. 31, 2009  1,893,340,600                                            
Common stock cancelled (In shares)  (33,333,333)                                            
Common stock cancelled(200,000) (3,333)(196,667)                                           
Conversion of convertible debentures and accrued interest into common stock (in shares)  52,302,696                                            
Conversion of convertible debentures and accrued interest into common stock233,550 5,230228,320                                           
Warrants recorded as contingent compensation253,308  253,308                                           
Reclassification of contracts to derivative liabilities due to commitment to issue shares in excess of amount authorized(356,806)  (356,806)                                           
Beneficial conversion features606,400  606,400                                           
Net loss(7,040,767)   (7,040,767)                                          
After the March 21, 2011, 200-to-1 reverse stock split:                                               
Common stock and warrants issued (in shares)                          42,021,649                    
Common stock and warrants issued                         456,3104,203452,107                   
Common stock issued (in shares)        40,000,000  27,686,567  37,000,000                       63,013,452  8,000,000  15,201,048  
Common stock issued      400,000 4,000396,000128,2002,769125,431143,9633,700140,263                     459,9986,301453,69768,00080067,200178,0001,520176,480 
Ending Balance at Dec. 31, 2010(5,729,164) 214,52421,128,703(27,072,391)                                          
Ending Balance (in shares) at Dec. 31, 2010  2,145,232,679                                           10,726,163
Adjustment for 200-to-1 reverse common stock split  (213,451)213,451                                           
Conversion of convertible debentures and accrued interest into common stock (in shares)  1,268,077                                            
Conversion of convertible debentures and accrued interest into common stock331,868 127331,741                                           
Warrants recorded as contingent compensation80,478  80,478                                           
Common stock options awarded as compensation for past services1,691,126  1,691,126                                           
Beneficial conversion features258,328  258,328                                           
Net loss(6,142,744)   (6,142,744)                                          
After the March 21, 2011, 200-to-1 reverse stock split:                                               
Issuance of preferred stock to directors (in shares)       50,000                                       
Issuance of preferred stock to directors      12,8005 12,795                                     
Common stock and warrants issued (in shares)           257,424  45,000  20,000  295,000     1,449,414                    
Common stock and warrants issued          110,00026109,974150,3274150,323117,5892117,587357,32030357,290   549,916145549,771                   
Common stock issued (in shares)                       213,638     390,000                 
Common stock issued                      65,8702165,849   244,80039244,761                
Ending Balance at Jun. 30, 2011$ (7,901,486)$ 5$ 1,467$ 25,312,177$ (33,215,135)                                          
Ending Balance (in shares) at Jun. 30, 2011 50,00014,664,993